BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18274729)

  • 1. Tumor necrosis factor-alpha-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase.
    Palin K; McCusker RH; Strle K; Moos F; Dantzer R; Kelley KW
    Psychopharmacology (Berl); 2008 May; 197(4):629-35. PubMed ID: 18274729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFalpha-induced sickness behavior.
    Palin K; Bluthé RM; McCusker RH; Levade T; Moos F; Dantzer R; Kelley KW
    Psychopharmacology (Berl); 2009 Jan; 201(4):549-56. PubMed ID: 18825372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice.
    Bluthé RM; Kelley KW; Dantzer R
    Brain Behav Immun; 2006 Jan; 20(1):57-63. PubMed ID: 16364817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFalpha-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I.
    Palin K; Bluthé RM; McCusker RH; Moos F; Dantzer R; Kelley KW
    J Neuroimmunol; 2007 Jul; 187(1-2):55-60. PubMed ID: 17512609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage.
    Nijboer CH; Bonestroo HJ; Zijlstra J; Kavelaars A; Heijnen CJ
    Neurobiol Dis; 2013 Jun; 54():432-44. PubMed ID: 23376684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity.
    Eshraghi AA; Wang J; Adil E; He J; Zine A; Bublik M; Bonny C; Puel JL; Balkany TJ; Van De Water TR
    Hear Res; 2007 Apr; 226(1-2):168-77. PubMed ID: 17098385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of c-Jun N-terminal kinase after hemorrhage but before resuscitation mitigates hepatic damage and inflammatory response in male rats.
    Relja B; Schwestka B; Lee VS; Henrich D; Czerny C; Borsello T; Marzi I; Lehnert M
    Shock; 2009 Nov; 32(5):509-16. PubMed ID: 19295484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
    Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
    Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal long-term depression is enhanced, depotentiation is inhibited and long-term potentiation is unaffected by the application of a selective c-Jun N-terminal kinase inhibitor to freely behaving rats.
    Yang H; Courtney MJ; Martinsson P; Manahan-Vaughan D
    Eur J Neurosci; 2011 May; 33(9):1647-55. PubMed ID: 21453290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
    Strle K; Broussard SR; McCusker RH; Shen WH; LeCleir JM; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2006 Sep; 147(9):4363-73. PubMed ID: 16777978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
    Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
    Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo.
    Milano G; Morel S; Bonny C; Samaja M; von Segesser LK; Nicod P; Vassalli G
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1828-35. PubMed ID: 17158645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide.
    Park SE; Lawson M; Dantzer R; Kelley KW; McCusker RH
    J Neuroinflammation; 2011 Dec; 8():179. PubMed ID: 22189158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss.
    Wang J; Van De Water TR; Bonny C; de Ribaupierre F; Puel JL; Zine A
    J Neurosci; 2003 Sep; 23(24):8596-607. PubMed ID: 13679429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression.
    Lawson MA; Kelley KW; Dantzer R
    Brain Behav Immun; 2011 Nov; 25(8):1569-75. PubMed ID: 21620953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice.
    Bluthé RM; Layé S; Michaud B; Combe C; Dantzer R; Parnet P
    Eur J Neurosci; 2000 Dec; 12(12):4447-56. PubMed ID: 11122355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways.
    Guan QH; Pei DS; Zong YY; Xu TL; Zhang GY
    Neuroscience; 2006 May; 139(2):609-27. PubMed ID: 16504411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
    Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.
    Bluthé RM; Pawlowski M; Suarez S; Parnet P; Pittman Q; Kelley KW; Dantzer R
    Psychoneuroendocrinology; 1994; 19(2):197-207. PubMed ID: 8190839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the c-Jun N-terminal kinase pathway in retinal excitotoxicity, and neuroprotection by its inhibition.
    Bessero AC; Chiodini F; Rungger-Brändle E; Bonny C; Clarke PG
    J Neurochem; 2010 Jun; 113(5):1307-18. PubMed ID: 20345748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.